Patents Represented by Attorney Roylance Abrams
  • Patent number: 7763604
    Abstract: This invention relates to methods of inhibiting growth and/or proliferation of a neoplastic cell, and methods of treating neoplasms by administration of the farnesylated dibenzodiazepinone compound of Formula I via continuous intravenous infusion.
    Type: Grant
    Filed: May 16, 2006
    Date of Patent: July 27, 2010
    Assignee: Thallion Pharma Ceuticals, Inc.
    Inventors: Henriette Gourdeau, Maxime Ranger, François Berger, Bryan Simard
  • Patent number: D558883
    Type: Grant
    Filed: September 29, 2006
    Date of Patent: January 1, 2008
    Assignee: Becton, Dickinson and Company
    Inventor: David Ortiz